Trial intelligence / Profile preview

Phenylephrine ED90 for Post-Spinal Hypotension in Preeclampsia

NCT06151470Not yet recruiting

Sponsor
General Hospital of Ningxia Medical University
Start
Jul 2025
Primary completion
Dec 2025
Modality
Small Molecules
01

Overview

Randomised trial of phenylephrine in hypotension (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoint: Effective Dose 50 and Effective Dose 90 of Phenylephrine. Planned start Jul 2025; status: not yet recruiting.

02

Drugs

phenylephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT06151470.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06151470.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call